Loading…
Loading…
FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier performance.
Baader Bank Aktiengesellschaft grew its holdings in AbbVie Inc. (NYSE: ABBV) by 560.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,380 shares of the company's stock after buying an additional 6,263 shares during the period. Baader
Andra AP fonden lifted its holdings in AbbVie Inc. (NYSE: ABBV) by 44.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 283,811 shares of the company's stock after purchasing an additional 86,969 shares during the quarter.
PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yield beats IXJ by 50 basis points.
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.
Dimensional Fund Advisors LP lowered its stake in AbbVie Inc. (NYSE: ABBV) by 10.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,411,238 shares of the company's stock after selling 868,264 shares during the period. AbbVie accounts for about 0.3% of Dimensional
AbbVie will fund this acquisition with debt, leaving its cash reserves intact. The company should maintain its dividend program as it did after previous massive acquisitions.
The three biggest US pharma names by market cap trade at very different setups right now: Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) at $247.02 screens as the most compelling on fundamentals, Eli Lilly (NYSE:LLY) at $1,156.63 looks fully valued, and AbbVie (NYSE:ABBV) at $244.11 appears stretched relative to its growth outlook.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for ABBV and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.